The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zolpidem Tartrate 5 mg Film-coated Tablets

5 milligram(s) Film-coated tablet

Key Pharmaceuticals LtdPA0343/005/001

Main Information

Trade NameZolpidem Tartrate 5 mg Film-coated Tablets
Strength5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderKey Pharmaceuticals Ltd
Licence NumberPA0343/005/001

Group Information

ATC CodeN05CF Benzodiazepine related drugs
N05CF02 zolpidem


Licence Issued19/05/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations, 2017
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back